This report examines (1) the representation of women on boards of U.S. publicly-traded companies and factors that may affect it and (2) selected stakeholders’ views on strategies for increasing representation of women on corporate boards.
This is a model charitable contribution acknowledgement letter to be sent to a donor.
This article presents the full year of 2015 data and reflects recent developments related to proxy access in the United States.
One topic activists are not bringing to the table is diversity, even though more boards than ever want a mix of women and men as well races and nationalities.
This article refers to the Hong Kong Monetary Authority (the “HKMA”) near final version of the draft module in the HKMA Supervisory Policy Manual on margin and risk mitigation standards for non-centrally cleared OTC derivatives (the “SPM Margin Module”), together with the HKMA’s response to comments from the various industry bodies on the HKMA consultation response.
This article shows how companies are deciding that sometimes it’s better to compromise than mount aggressive defenses. Putting an activist on a board early avoids the costs, distractions and reputational damages risked in a potential proxy fight—and brings behind closed doors contentious discussions about spinoffs, buybacks or asset sales. It also reflects the heightened pressure on corporate directors to show they’re acting on behalf of shareholders and willing to buck management.
Prior to deployment, travellers should be briefed on the current threat and the necessary level of awareness, as well as the range of possible targets, in order to adjust their plans accordingly.
This is an act to amend Title 8 of the Delaware Code relating to the General Counsel Corporation law.
This paper seeks to provide a framework for boards to build a renewal process that increases accountability and achieves the right mix of skills and experience to create long-term effectiveness in the United States.
This article addresses how pharmaceutical companies take precautions against activist firms when using their shares as currency for an acquisition. These bans have gone largely unnoticed by the activist managers, who say shareholders may be harmed when a company limits who can buy its shares.